ropivacaine + betamethasone

Ropivacaine + betamethasone is a combination of two pharmaceutical agents used primarily for local infiltration analgesia in surgical settings, particularly for postoperative pain management. Ropivacaine is an amide-type local anesthetic that blocks nerve impulse transmission by inhibiting sodium channels, resulting in loss of sensation and pain relief at the site of administration. Betamethasone is a long-acting synthetic corticosteroid with potent anti-inflammatory properties; it reduces inflammation and immune responses by modulating gene expression through the glucocorticoid receptor. When combined, these drugs provide synergistic effects—ropivacaine offers immediate local anesthesia while betamethasone prolongs analgesic duration and reduces postoperative opioid requirements due to its sustained anti-inflammatory action. This combination has been studied in procedures such as laminoplasty, laminectomy, craniotomy, and intercostal nerve block for chronic post-thoracotomy pain[1][4][5][6][8]. However, there are concerns about physicochemical instability (precipitation/crystallization) when mixed together[2][3].

Brand names

Diprospan + ropivacaine

Other names

Ropivacaine and DiprospanRopivacaine with DiprospanBetamethasone and ropivacaine